Jiangsu Hengrui Pharmaceuticals Co., Ltd.

13D and 13G Filings

13D/G filings
13G on 2 securities
CIK
0002080343
All SEC filings
View on sec.gov
Issuer % of Class Filed
Schedule 13G · 2 securities · passive
Braveheart Bio, Inc. 13G
BRVE · 10567X101
8.2% 11/9/2026
Event 9/30/2026
Kailera Therapeutics, Inc. 13G
KLRA · 482931102
8.9% 8/5/2026
Event 6/30/2026

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.